127 related articles for article (PubMed ID: 8249131)
1. A comparative study of cyclosporine and its derivative SDZ IMM-125 in canine renal allografts.
Watson CJ; Metcalfe SM; St John Collier DG; Calne RY
Transplantation; 1993 Nov; 56(5):1248-50. PubMed ID: 8249131
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat.
Chen H; Qi S; Xu D; Bergeron E; Wu J; Beauregard-Zollinger L; Tan A; Daloze P
Clin Immunol Immunopathol; 1996 Jul; 80(1):76-81. PubMed ID: 8674242
[TBL] [Abstract][Full Text] [Related]
3. A new cyclosporin derivative, SDZ-IMM-125, prolongs renal allograft survival in dogs.
Esmeraldo R; al-Shaibani K; Gray DW; Dunnill MS; Mason J; Morris PJ
Transpl Immunol; 1995 Jun; 3(2):167-73. PubMed ID: 7582908
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular effects of cyclosporine A and its derivative SDZ IMM 125 in vitro.
Wolf A; Schramm U; Fahr A; Aicher L; Cordier A; Trommer WE; Fricker G
J Pharmacol Exp Ther; 1998 Mar; 284(3):817-25. PubMed ID: 9495838
[TBL] [Abstract][Full Text] [Related]
5. New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Donatsch P; Ryffel B; Borel JF
Transplant Proc; 1993 Feb; 25(1 Pt 1):691-2. PubMed ID: 8438439
[No Abstract] [Full Text] [Related]
6. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
[TBL] [Abstract][Full Text] [Related]
7. Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.
Milovancev M; Schmiedt CW; Bentley E; Schwab M; Dubielzig RR; Gendron-Fitzpatrick AP; McAnulty JF
Vet Surg; 2007 Jan; 36(1):10-20. PubMed ID: 17214815
[TBL] [Abstract][Full Text] [Related]
8. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
Bruelisauer A; Kawai R; Misslin P; Lemaire M
Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of leflunomide in the canine renal transplantation model.
McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
[TBL] [Abstract][Full Text] [Related]
11. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE
Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474
[No Abstract] [Full Text] [Related]
12. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
13. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Sandimmun with a new cyclosporin derivative (IMM 125) in renal transplant patients with stable renal function. IMM 125 Multicentre Study Group.
Hoitsma AJ
Transpl Int; 1996; 9 Suppl 1():S314-7. PubMed ID: 8959854
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the O-hydroxyethyl-D(Ser)(8)-cyclosporine A derivative SDZ IMM 125 in rat hepatocytes.
Grub S; Persohn E; Trommer WE; Wolf A
J Pharmacol Exp Ther; 2000 Apr; 293(1):24-32. PubMed ID: 10734149
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
[TBL] [Abstract][Full Text] [Related]
18. Toxicologic evaluation of the new cyclosporin derivative, SDZ IMM 125, in a comparative, subchronic toxicity study in rats.
Donatsch P; Mason J; Richardson BP; Ryffel B
Transplant Proc; 1992 Aug; 24(4 Suppl 2):39-42. PubMed ID: 1496685
[No Abstract] [Full Text] [Related]
19. Uptake and metabolism of cyclosporin A and SDZ IMM 125 in the human in vitro skin2 dermal and barrier function models.
Vickers AE; Biggi WA; Dannecker R; Fischer V
Life Sci; 1995; 57(3):215-24. PubMed ID: 7596228
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
